These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38725175)

  • 21. Aggressive hydration with lactated Ringer's solution versus plasma solution for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (ALPS study): protocol for a multicentre, double-blind, randomised controlled trial.
    Cho IR; Choi JH; Park JK; Huh G; Lee SH; Paik WH; Park DH
    BMJ Open; 2024 Jul; 14(7):e084052. PubMed ID: 38955368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial.
    Sotoudehmanesh R; Ali-Asgari A; Khatibian M; Mohamadnejad M; Merat S; Sadeghi A; Keshtkar A; Bagheri M; Delavari A; Amani M; Vahedi H; Nasseri-Moghaddam S; Sima A; Eloubeidi MA; Malekzadeh R
    Endoscopy; 2019 Oct; 51(10):915-921. PubMed ID: 31454851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
    Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive Hydration With Ringer's Lactate in the Prevention of Post-ERCP Pancreatitis: A Meta-Analysis.
    Aljohani S; Mirghani H
    Cureus; 2021 May; 13(5):e14897. PubMed ID: 34109084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis.
    Akshintala VS; Hutfless SM; Colantuoni E; Kim KJ; Khashab MA; Li T; Elmunzer BJ; Puhan MA; Sinha A; Kamal A; Lennon AM; Okolo PI; Palakurthy MK; Kalloo AN; Singh VK
    Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1325-37. PubMed ID: 24138390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
    Rustagi T; Njei B
    Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
    Shen C; Shi Y; Liang T; Su P
    Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
    Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
    Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials.
    Yu G; Li S; Wan R; Wang X; Hu G
    Pancreas; 2015 May; 44(4):561-9. PubMed ID: 25822153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis.
    Liu L; Li C; Huang Y; Jin H
    J Gastrointest Surg; 2019 Oct; 23(10):1991-2001. PubMed ID: 30251071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis.
    Dubravcsik Z; Hritz I; Keczer B; Novák P; Lovász BD; Madácsy L
    Pancreatology; 2021 Jun; 21(4):704-713. PubMed ID: 33926821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
    Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
    Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Latest Knowledge on Endoscopic Retrograde Cholangiopancreatography-related Pancreatitis].
    Park CH
    Korean J Gastroenterol; 2022 May; 79(5):195-198. PubMed ID: 35610548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis.
    Yang J; Wang W; Liu C; Zhao Y; Ren M; He S
    J Clin Gastroenterol; 2020 Apr; 54(4):305-313. PubMed ID: 32011404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.
    Tomoda T; Kato H; Ueki T; Akimoto Y; Hata H; Fujii M; Harada R; Ogawa T; Wato M; Takatani M; Matsubara M; Kawai Y; Okada H
    Gastroenterology; 2019 May; 156(6):1753-1760.e1. PubMed ID: 30772342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography.
    Brand M; Bizos D; O'Farrell P
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007345. PubMed ID: 20927758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.